Use this new report to easily answer key business questions such as:
Which orthopaedic sector is forecast to grow to US$8.3 billion by 2015?
At the time of publication, there were 19 significant acquisitions in 2011 – who were the buyers, and how will it affect their market position in the future?
Which region of the world is expected to achieve a CAGR approaching 10%?
Which country posted the fastest growth in 2010 for hip and knee replacement procedures?
What is the market share of the leading companies?
Why would those interested in the spine market particularly note the performance of Alphatec Spine, Anika Therapeutics and Medicrea?
What strengths does BioMimetic have in the competitive orthobiologics sector
A complete analysis packed with facts, forecasts and
detailed company evaluations
Mergers & Acquisitions: a return of capital sees activity levels increase
After a quiet 2009, 2010 saw a return to confidence with a number of substantial acquisitions going through. In March 2010, Baxter International announced the US$330 million takeover of ApaTech, a UK company specialising in orthobiologics. Also in March, Alphatec Spine went ahead with a US$127 million deal to acquire Scient'x, the French spinal devices developer. Towards the end of the year, Medtronic continued with its aggressive growth strategy and strengthened its orthobiologics operations by acquiring Osteotech in a US$123 million transaction. If further evidence was needed of changing times, it can be found in the April 2011 announcement of Johnson & Johnson's (DePuy) US$21.3 billion takeover of Synthes; the first 'mega-deal' since Biomet was bought out in 2007 and which has consolidated DePuy's status as the global leader in orthopaedics.
Spine and Orthobio
Copyright©2010 PR Newswire.
All rights reserved